Abstract:Transcriptional enhancers function as nucleation sites for the assembly of transcription-regulating complexes across the genome, which act to drive cell type-specific patterns of gene expression. Although many features of active enhancers [e.g., H3K4me1, H3K27ac, enrichment of p300/CBP and Mediator, and production of enhancer RNAs (eRNAs)] have been defined by genomic assays, the roles of these features in estrogen receptor alpha (ERa) enhancer function are not well understood. We are interested in how the molecular underpinnings of ERa enhancer formation and activity control the gene expression programs that drive breast cancer phenotypes and responses to therapeutic agents. We have used a variety of molecular, biochemical, genomic, genetic, and computational approaches to determine the following aspects of ERa enhancers biology in hormone-responsive breast cancer cells: (1) where ERa enhancers are formed across the genome, (2) the kinetics of ERa enhancer formation and disassembly, (3) the influence of genetic variation on ERa enhancer function, (4) the role of the enhancer features noted above in ERa enhancer function, and (5) how protein complexes and small polypeptides serve as coregulators to drive ERa transcriptional activity. Our current focus has been on eRNAs, which are poorly characterized noncoding RNAs that are thought to regulate enhancer function and gene expression. We have identified a ~40 nucleotide functional eRNA regulatory motif (FERM) present in many estrogen-regulated eRNAs that promotes gene expression by increasing ERα recruitment and stimulating p300-catalyzed H3K27 acetylation. In addition, we have been examining how the dose of estrogen impacts the efficiency of enhancer assembly by ERα. Finally, we have been exploring the role of PARP1, a ubiquitous chromatin-associated regulator, and small polypeptides derived from "non-coding" RNAs, control ERa enhancer function. In all cases, we perform analyses to link enhancer function to gene expression outcomes and breast cancer biology. Collectively, our results demonstrate the biological and mechanistic roles of eRNAs in breast cancer. This work is supported by grants from the NIH/NIDDK (DK058110) and CPRIT (RP160319) to W.L.K. Citation Format: W. Lee Kraus. Molecular and genomic mechanisms of estrogen signaling and gene regulation in breast cancer [abstract]. In: Proceedings of the AACR Special Conference in Cancer Research: Advances in Breast Cancer Research; 2023 Oct 19-22; San Diego, California. Philadelphia (PA): AACR; Cancer Res 2024;84(3 Suppl_1) nr IA13.

Phase separation of ligand-activated enhancers licenses cooperative chromosomal enhancer assembly

Role of Nuclear Receptor Condensates in Ligand Induced Co‐operative Gene Regulation

Condensin I and II Complexes License Full Estrogen Receptor Α-Dependent Enhancer Activation.

Assessing eRNAs associated with a cytokine-sensing mammary super-enhancer

Histone H3 Lysine 4 Monomethylation Modulates Long-Range Chromatin Interactions at Enhancers

Coactivator condensation at super-enhancers links phase separation and gene control

The interplay between phase-separation and gene-enhancer communication: a theoretical study

Enhancer RNAs Mediate Estrogen-Induced Decommissioning of Selective Enhancers by Recruiting Erα and Its Cofactor

Transcription decouples estrogen-dependent changes in enhancer-promoter contact frequencies and spatial proximity

Hormone-induced enhancer assembly requires an optimal level of hormone receptor multivalent interactions

Fluctuating chromatin facilitates enhancer-promoter communication by regulating transcriptional clustering dynamics

Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer

Cohesin-mediated 3D contacts tune enhancer-promoter regulation

Phase separation drives aberrant chromatin looping and cancer development

Loci-specific phase separation of FET fusion oncoproteins promotes gene transcription

Mediator and RNA polymerase II clusters associate in transcription-dependent condensates

Abstract IA13: Molecular and genomic mechanisms of estrogen signaling and gene regulation in breast cancer

Dynamic network-guided CRISPRi screen identifies CTCF-loop-constrained nonlinear enhancer gene regulatory activity during cell state transitions

Synergy between cis-regulatory elements can render cohesin dispensable for distal enhancer function

Epigenetic Plasticity of Enhancers in Cancer

Dismissal of RNA Polymerase II Underlies a Large Ligand-Induced Enhancer Decommissioning Program.